According to a ranking of the best hospitals in the U.S., the best hospital for adult cardiology, heart, and vascular surgery is the Cleveland Clinic in Ohio, which had a score of 100 out of 100, as of 2024. This statistic shows the top 10 hospitals for adult cardiology, heart, and vascular surgery in the United States based on the score given by U.S. News and World Report's annual hospital ranking.

This statistic shows the number of beds in the top 10 hospitals for adult cardiology and heart surgery in the United States, as of 2017, according to the latest U.S. News Best Hospitals report. The highest number of beds among the top 10 adult cardiology hospitals was in the New York-Presbyterian University Hospital of Columbia and Cornell with 2,381 beds in total within this specialty.

This statistic shows the number of doctors in the top 10 hospitals for adult cardiology and heart surgery in the United States, as of 2016, according to the latest U.S. News Best Hospitals report. The highest number among the top 10 adult cardiology hospitals was reported for the Mount Sinai Hospital of New York with 440 doctors within this specialty area.

Abstract Background There are substantial opportunities to improve the quality of cardiovascular care in developing countries through the implementation of a quality program. Objective To evaluate the effect of a Best Practice in Cardiology (BPC) program on performance measures and patient outcomes related to heart failure, atrial fibrillation and acute coronary syndromes in a subset of Brazilian public hospitals. Methods The Boas Práticas em Cardiologia (BPC) program was adapted from the American Heart Association’s (AHA) Get With The Guidelines (GWTG) Program for use in Brazil. The program is being started simultaneously in three care domains (acute coronary syndrome, atrial fibrillation and heart failure), which is an approach that has never been tested within the GWTG. There are six axes of interventions borrowed from knowledge translation literature that will address local barriers identified through structured interviews and regular audit and feedback meetings. The intervention is planned to include at least 10 hospitals and 1,500 patients per heart condition. The primary endpoint includes the rates of overall adherence to care measures recommended by the guidelines. Secondary endpoints include the effect of the program on length of stay, overall and specific mortality, readmission rates, quality of life, patients’ health perception and patients’ adherence to prescribed interventions. Results It is expected that participating hospitals will improve and sustain their overall adherence rates to evidence-based recommendations and patient outcomes. This is the first such cardiovascular quality improvement (QI) program in South America and will provide important information on how successful programs from developed countries like the United States can be adapted to meet the needs of countries with developing economies like Brazil. Also, a successful program will give valuable information for the development of QI programs in other developing countries. Conclusions This real-world study provides information for assessing and increasing adherence to cardiology guidelines in Brazil, as well as improvements in care processes. (Arq Bras Cardiol. 2019; xx(x):xxx-xxx)

In 2019, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo in Brazil ranked first in hospitals with highest focus on cardiovascular health in Latin America, with a total of ***** equipment pieces dedicated to cardiovascular health. It was followed by Santa Casa de Misericórdia de Porto Alegre in Brazil with *** equipment pieces.

Children's specialty hospitals represent less than 5% of all US hospitals but are vital to pediatric healthcare. Despite the disruptions caused by the pandemic, the industry experienced growth because of the inelastic demand for children's health services. While the pandemic raised operating costs, the adoption of telemedicine and government support helped mitigate significant declines in demand and revenue. The income and expense volatility in the recent period did not impact industry-wide revenue, which is expected to climb at a CAGR of 0.2% through 2024 to total $49.1 billion, increasing 1.0% in 2024. According to the American Academy of Pediatrics, children's hospitals often care for children than depend on Medicaid funds. Yet, hospitals receive only about two-thirds of the reimbursement for the total cost of care. Increased managed care, capitation payment agreements and state policy changes influencing Medicaid reimbursements can further impact payouts. Also, children's specialty hospitals face ongoing physician and nurse shortages, leading to a competitive environment that drives up wages. Despite these regulatory pressures and competition from general hospitals, children's specialty hospitals can rely on support from various industry associations, foundations and charities. Consolidation has become a common strategy to counter competitive forces and achieve economies of scale. However, advancements in telemedicine and innovations in wearables and medical devices could shift services away from specialty hospitals to other healthcare providers. Nonetheless, demand for services from children's specialty hospitals is expected to remain strong in response to the increasing prevalence of conditions such as asthma, obesity, diabetes and congenital anomalies among individuals under 18. By meeting this demand, industry revenue is predicted to strengthen at a CAGR of 3.0% through the end of 2029, reaching $56.9 billion, with profit expected to recover and surpass pre-pandemic levels.

Snapshot img

Heart-Lung Machines Market Size 2024-2028

The heart-lung machines market size is forecast to increase by USD 168.1 billion at a CAGR of 3.3% between 2023 and 2028.

The heart-lung machine market is experiencing significant growth due to several key drivers. One of the primary factors is the increasing trend of medical tourism in Asia, which is leading to a higher demand for advanced medical equipment, including heart-lung machines. Another trend is the development of portable heart-lung machines, which offer greater mobility and flexibility for medical professionals. However, the market also faces challenges, such as the complications associated with coronary artery bypass grafting (CABG) surgeries, which can increase the need for heart-lung machines. These complications include bleeding, infection, and stroke, among others. Despite these challenges, the market is expected to continue growing due to the increasing demand for advanced medical equipment and the ongoing development of new technologies.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market is expected to experience significant growth due to the increasing prevalence of cardiovascular disorders, particularly in the geriatric population. These machines play a crucial role in supporting the heart and lungs during surgeries such as open-heart surgery, transplant surgeries, and heart valve surgeries. The clinical benefits of heart-lung machines are immense, enabling skilled medical professionals to perform complex procedures with precision. Advanced technology and engineering have led to the development of specialized cardiac centers equipped with sophisticated medical devices, including cardiopulmonary bypass machines and heart-lung machines. FDA clearance for these devices ensures their safety and efficacy in treating various cardiovascular diseases, lung diseases, and respiratory failure.
Heart-lung machines are essential in healthcare facilities for treating stress-induced cardiac and respiratory conditions, as well as those resulting from unhealthy food habits. The healthcare system relies heavily on these machines for organ transplants, offering new life to patients suffering from heart implants and other cardiovascular ailments. The market for heart-lung machines is expected to continue growing, driven by the increasing demand for advanced medical devices in the healthcare industry. The cardiopulmonary bypass machine plays a crucial role in cardiac and lung surgeries by oxygenating blood and removing carbon dioxide. With an aging population, miniaturized and portable systems are becoming essential. Advanced heart-lung machines featuring a double roller pump ensure optimal blood flow and circulation, requiring careful maintenance and servicing for biocompatibility.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Hospitals
  ASCs


Application

  Heart surgery
  Heart failure
  Lung surgery


Geography

  North America

    US


  Europe

    Germany
    France


  Asia

    China
    Japan


  Rest of World (ROW)

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period.

The market is witnessing significant growth due to the increasing number of transplant surgeries in the geriatric population. These medical devices, which include pumps, oxygenators, and monitoring systems, play a crucial role in maintaining organ function during surgeries for conditions such as coronary artery disease, heart failure, valvular heart disease, and congenital heart diseases. Specialized cardiac centers are investing in advanced technology to improve clinical benefits and ensure patient safety during elective surgeries. Engineering innovations in heart-lung machines have led to the development of specialized features like single roller pumps, safety mechanisms, bubble detectors, air removal systems, pressure alarms, and occlusion sensors.

These technologies help prevent complications such as hemolysis, organ ischemia, and tissue damage during surgical procedures. Surgical volume is increasing due to infection control protocols and minimally invasive procedures like CABG surgeries, robotic-assisted surgeries, and transcatheter interventions. Hospitals and clinics are focusing on therapeutic outcomes to enhance patient visits and overall satisfaction. According to WHO data, the number of cardiac surgeries is projected to grow, driving the demand for heart-lung machines in the healthcare industry.

Get a glance at the market report of share of various segments Request Free Sample

The Hospitals segment was val

Background and aimsHeart failure (HF) is a significant cause of in-hospital mortality, especially for the elderly admitted to intensive care units (ICUs). This study aimed to develop a web-based calculator to predict 30-day in-hospital mortality for elderly patients with HF in the ICU and found a relationship between risk factors and the predicted probability of death.Methods and resultsData (N = 4450) from the MIMIC-III/IV database were used for model training and internal testing. Data (N = 2,752) from the eICU-CRD database were used for external validation. The Brier score and area under the curve (AUC) were employed for the assessment of the proposed nomogram. Restrictive cubic splines (RCSs) found the cutoff values of variables. The smooth curve showed the relationship between the variables and the predicted probability of death. A total of 7,202 elderly patients with HF were included in the study, of which 1,212 died. Multivariate logistic regression analysis showed that 30-day mortality of HF patients in ICU was significantly associated with heart rate (HR), 24-h urine output (24h UOP), serum calcium, blood urea nitrogen (BUN), NT-proBNP, SpO2, systolic blood pressure (SBP), and temperature (P < 0.01). The AUC and Brier score of the nomogram were 0.71 (0.67, 0.75) and 0.12 (0.11, 0.15) in the testing set and 0.73 (0.70, 0.75), 0.13 (0.12, 0.15), 0.65 (0.62, 0.68), and 0.13 (0.12, 0.13) in the external validation set, respectively. The RCS plot showed that the cutoff values of variables were HR of 96 bmp, 24h UOP of 1.2 L, serum calcium of 8.7 mg/dL, BUN of 30 mg/dL, NT-pro-BNP of 5121 pg/mL, SpO2 of 93%, SBP of 137 mmHg, and a temperature of 36.4°C.ConclusionDecreased temperature, decreased SpO2, decreased 24h UOP, increased NT-proBNP, increased serum BUN, increased or decreased SBP, fast HR, and increased or decreased serum calcium increase the predicted probability of death. The web-based nomogram developed in this study showed good performance in predicting 30-day in-hospital mortality for elderly HF patients in the ICU.

As of January 2025, there were a total of 566,723 specialty physicians active in the United States. Of these, most were specialized in emergency medicine. Physician compensation Significant pay variations exist across specialties and regions, with orthopedic doctors and surgeons command the highest average annual salaries at 558,000 U.S. dollars. Meanwhile, the West North Central area offers the highest average physician compensation at 404,000 U.S. dollars annually. This region's higher pay likely stems from lower physician density in rural areas, creating less competition. Interestingly, doctors in Northeastern and Southwestern parts of the United States tend to earn less than their counterparts in other regions. Burnout among physicians Despite high salaries, U.S. physicians face high workload and stress in the workplace. Nearly half of surveyed doctors reported feeling burnout, with higher burnout rates among female doctors, younger physicians, and those in primary care compared to their counterparts. More effort to combat burnout is needed in the healthcare system. Increasing compensation was cited by physicians as the top measure to alleviate burnout, followed by adding support staff and offering more flexible schedules.

4-D Flow Cardiac MRI Software Market Outlook

According to our latest research conducted in 2025, the global 4-D Flow Cardiac MRI Software market size is valued at USD 162.5 million in 2024. The market is anticipated to expand at a robust CAGR of 14.2% during the forecast period, reaching an estimated USD 422.4 million by 2033. This significant growth is primarily fueled by the increasing prevalence of cardiovascular diseases, rapid advancements in MRI technology, and a growing emphasis on non-invasive diagnostic modalities across healthcare systems worldwide. The market is witnessing a surge in adoption as healthcare providers prioritize precision diagnostics and workflow efficiency to improve patient outcomes in cardiology.

The growth trajectory of the 4-D Flow Cardiac MRI Software market is strongly influenced by the rising incidence of cardiovascular disorders globally. As per the World Health Organization, cardiovascular diseases remain the leading cause of mortality, accounting for over 17.9 million deaths annually. This alarming statistic is prompting healthcare professionals to seek advanced imaging solutions for early detection, comprehensive assessment, and effective management of cardiac conditions. 4-D Flow Cardiac MRI Software enables clinicians to visualize and quantify complex blood flow patterns in the heart and great vessels, offering unprecedented insights into hemodynamics. This capability is particularly valuable for diagnosing congenital heart defects, valvular abnormalities, and aortic diseases, thereby driving widespread adoption of these solutions.

Another key growth factor is the technological evolution in MRI hardware and software platforms. The integration of artificial intelligence and machine learning algorithms into 4-D Flow Cardiac MRI Software has enhanced image reconstruction speeds, improved accuracy, and reduced artifacts. These advancements are making cardiac MRI more accessible and user-friendly for radiologists and cardiologists, while also reducing scan times and patient discomfort. Furthermore, the proliferation of cloud-based deployment models is enabling seamless data sharing, remote collaboration, and scalable storage, which are crucial for multi-center clinical trials and telemedicine applications. As vendors continue to invest in R&D and forge collaborations with leading medical institutions, the market is poised for sustained innovation and expansion.

The expanding geriatric population and increasing healthcare expenditure in both developed and emerging economies are also contributing to market growth. Elderly individuals are particularly susceptible to cardiovascular diseases, necessitating advanced diagnostic tools for accurate evaluation and timely intervention. Governments and healthcare organizations are allocating substantial resources to upgrade imaging infrastructure and train personnel in the use of sophisticated cardiac MRI software. Additionally, favorable reimbursement policies for cardiac imaging procedures in regions such as North America and Europe are encouraging hospitals and diagnostic centers to invest in 4-D Flow Cardiac MRI Software. Collectively, these factors are creating a conducive environment for market growth, with emerging markets in Asia Pacific and Latin America offering untapped potential.

Regionally, North America dominates the 4-D Flow Cardiac MRI Software market, driven by a high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and a strong focus on technological innovation. Europe follows closely, supported by government initiatives to modernize healthcare systems and promote early diagnosis of cardiac conditions. The Asia Pacific region is expected to witness the fastest CAGR during the forecast period, propelled by increasing healthcare investments, rising awareness about advanced diagnostic modalities, and a rapidly growing patient population. Meanwhile, Latin America and the Middle East & Africa are gradually embracing cardiac MRI technologies, albeit at a slower pace due to budgetary constraints and limited access to skilled professionals. Nevertheless, ongoing efforts to improve healthcare access and infrastructure are expected to drive steady market growth in these regions.

The Tempe Fire Medical Rescue Department (TFMR) is an “all hazards” department that responds to all types of calls for service. Cardiac arrest calls, when the heart stops beating, require specialized training and equipment to provide the best patient outcomes (chance of full recovery).

Data on the survival rate of patients who experience out of hospital cardiac arrest from cardiac origin in Tempe.

This page provides data for the Cardiac Arrest Survival Rate performance measure. The performance measure dashboard is available at 1.02 Cardiac Arrest Survival Rate

Additional Information

Source: https://azdhs.gov/preparedness/emergency-medical-services-trauma-system/save-hearts-az-registry-education/index.php

Contact:  Andrea Glass
Contact E-Mail:  andrea_glass@tempe.gov
Data Source Type:  CSV
Preparation Method: 
Publish Frequency:  Annual
Publish Method:  Manual

Data Dictionary

This statistic displays the leading hospitals in the United States based on the number of organ transplants performed between January 1988 and March 2025. During this period, the University of California at Los Angeles Medical Center performed ****** organ transplants in total. UCLA Medical Center was, therefore, the leading hospital in the U.S. in terms of organ transplant numbers, followed by the University of California San Francisco Medical Center.

A heart bypass is a surgical procedure where an artery or vein that feeds blood to the heart is redirected around an internal blockage in the vein or artery. The cost of such a procedure varies significantly globally. As of 2019, the U.S. had the highest costs of any country for a heart bypass. At that time the cost in the U.S. was about *** thousand U.S. dollars. Among countries compared, India had the lowest cost for a heart bypass at just under * thousand U.S. dollars.

Cardiovascular diseases

Cardiovascular diseases are a serious issue that can lead to heart attack and death if left untreated. As of 2016, the leading cause of death globally was ischemic heart disease. This is a condition that is caused by blockage of blood flow to the heart and is also referred to as coronary heart disease. Despite it being a major cause of death globally, within the U.S. the number of deaths due to heart diseases are on the decline. There are other types of heart diseases that can lead to sudden cardiac arrest including arrythmia.

Cardiac monitors market

Cardiac monitors and cardiac event recorders are one way that doctors can monitor patients with conditions such as arrythmia that can lead to sudden cardiac arrest. Arrythmia is a common condition among patients that have received a heart bypass surgery. The market for cardiac event monitors has been increasing in recent years and is projected to continue slowly increasing in the future. The revenue generated by the sales of these devices, however, is expected to nearly double by the year 2026, indicating a positive outlook for the market. A majority of the cardiac arrythmia monitoring devices globally are used in hospitals.

Abstract Background: Heart failure (HF) affects more than 5 million individuals in the United States, with more than 1 million hospital admissions per year. Cardiac resynchronization therapy (CRT) can benefit patients with advanced HF and prolonged QRS. A significant percentage of patients, however, does not respond to CRT. Electrical dyssynchrony isolated might not be a good predictor of response, and the last left ventricular (LV) segment to contract can influence the response. Objectives: To assess electromechanical dyssynchrony in CRT with LV lead implantation guided by GATED SPECT. Methods: This study included 15 patients with functional class II-IV HF and clinically optimized, ejection fraction of 35%, sinus rhythm, left bundle-branch block, and QRS ≥ 120 ms. The patients underwent electrocardiography, answered the Minnesota Living with Heart Failure Questionnaire (MLHFQ), and underwent gated myocardial perfusion SPECT up to 4 weeks before CRT, being reassessed 6 months later. The primary analysis aimed at determining the proportion of patients with a reduction in QRS duration and favorable response to CRT, depending on concordance of the LV lead position, using chi-square test. The pre- and post-CRT variables were analyzed by use of Student t test, adopting the significance level of 5%. Results: We implanted 15 CRT devices, and 2 patients died during follow-up. The durations of the QRS (212 ms vs 136 ms) and the PR interval (179 ms vs 126 ms) were significantly reduced (p < 0.001). In 54% of the patients, the lead position was concordant with the maximal delay site. In the responder group, the lateral position was prevalent. The MLHFQ showed a significant improvement in quality of life (p < 0.0002). Conclusion: CRT determines improvement in the quality of life and in electrical synchronism. Electromechanical synchronism relates to response to CRT. Positioning the LV lead in the maximal delay site has limitations.

The global medical equipment casters market is experiencing robust growth, driven by the increasing demand for advanced medical equipment and the rising prevalence of chronic diseases requiring specialized medical care. The market's expansion is fueled by several factors, including technological advancements leading to more sophisticated and mobile medical devices, the growing adoption of minimally invasive surgical procedures requiring maneuverable equipment, and the increasing focus on patient comfort and mobility within healthcare settings. The market is segmented by application (In Vitro Diagnostics, Cardiology, Diagnostic Imaging, Orthopedics, Others) and type (Bolt Hole Castors, Threaded Stem Castors, Top Plate Castors), with In Vitro Diagnostics and Cardiology segments showing particularly strong growth due to the high demand for mobile diagnostic and treatment equipment. Leading players are investing in research and development to enhance caster performance, durability, and hygiene features, catering to the stringent requirements of the medical industry. Geographic expansion is also a key driver, with emerging markets in Asia-Pacific and South America exhibiting significant growth potential as healthcare infrastructure improves. While regulatory hurdles and material cost fluctuations pose challenges, the overall market outlook remains positive, driven by sustained investment in healthcare infrastructure and technological innovation. The projected Compound Annual Growth Rate (CAGR) and substantial market size suggest a continuously expanding market. The competitive landscape is marked by both established global players and regional manufacturers, resulting in a dynamic market with ongoing innovation and price competition. Strategic partnerships and acquisitions are expected to increase as companies strive to expand their market share and product portfolios. Future market growth will depend on factors such as the pace of technological advancements in medical equipment, regulatory changes influencing medical device design and manufacturing, and the overall economic climate affecting healthcare investment. Further segmentation by end-user (hospitals, clinics, diagnostic centers) would provide a more granular understanding of market dynamics. The market is expected to maintain a steady growth trajectory throughout the forecast period (2025-2033), driven by sustained demand and the continuous evolution of medical equipment technology.

Snapshot img

Electrophysiology Market Size 2024-2028

The electrophysiology market size is forecast to increase by USD 6.09 billion at a CAGR of 10.71% between 2023 and 2028. The market is experiencing robust growth, driven by several key factors. The increasing incidence of target diseases and electrophysiology procedures is a significant contributor to this expansion. This trend is further fueled by the increasing uptake of mobile cardiac telemetry, which allows for remote patient monitoring and early detection of cardiac arrhythmias. Additionally, healthcare systems in emerging countries are undergoing reforms, expanding access to electrophysiology treatments for a larger patient population. Companies are prioritizing sustainability and operational efficiency to maintain a competitive edge. These dynamics are shaping the market's direction, supporting long-term growth. Innovative solutions and advancements in technology are also playing a crucial role in driving market expansion. As the demand for advanced electrophysiology solutions continues to grow, the market's scope is expanding to meet these needs. This evolution ensures that the industry remains at the forefront of medical technologies, providing the best possible care for patients.

What will be the size of the Electrophysiology Market during the forecast period?

Request Free Electrophysiology Market Sample

Electrophysiology Market Segmentation

The Electrophysiology market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

Product

  Lab devices
  Ablation catheters
  Diagnostic catheters
  Access devices


End-user

  Hospitals and cardiac centers
  ASCs


Geography

  North America

    US


  Europe

    Germany
    UK


  Asia

    China
    Japan


  Rest of World (ROW)

Which is the largest segment driving market growth?

The lab devices segment is estimated to witness significant growth during the forecast period.

Electrophysiology laboratories are specialized healthcare facilities equipped with advanced devices to diagnose and treat cardiovascular conditions, particularly arrhythmias and fibrillation. These conditions, including atrial flutter, hypertension, and diabetes, can lead to complications such as heart failure and stroke. Electrophysiology procedures involve the use of electrophysiological techniques, including catheter ablation, 3D mapping systems, and imaging modalities, to assess the electrical activity of the heart and provide real-time visualization for precise catheter placement and ablation treatments. The market for electrophysiology devices, including ablation catheters, radio frequency generators, and access devices, is driven by the increasing prevalence of chronic diseases, an aging population, and technological advancements.

Electrophysiology laboratories require capital investment for expensive equipment and the hiring of qualified electrophysiologists, specialized healthcare workers, and support staff. Regulatory support and medical care reimbursement policies also play a crucial role In the growth of this market. The integration of digital health technologies, such as digital cloud technology, telemedicine, and AI-powered mapping, is expected to further expand the market.

Get a glance at the market share of various regions. Download the PDF Sample

The Lab devices segment was valued at USD 2.76 billion in 2018 and showed a gradual increase during the forecast period.

Which region is leading the market?

North America is estimated to contribute 37% to the growth of the global Electrophysiology market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.The North American the market is experiencing consistent growth due to increasing awareness of cardiovascular diseases and arrhythmias, particularly atrial fibrillation (AF). Manufacturers are integrating electrophysiology devices, including ablation catheters and 3D mapping systems, into their product portfolios. Cardiovascular diseases, such as hypertension, diabetes, and heart failure, affect large populations, particularly the geriatric demographic. The demand for minimally invasive procedures and surgical interventions, like catheter ablation, is increasing. Electrophysiological techniques, like radiofrequency energy, are essential for these procedures. Regulatory support and medical care advancements enable better patient outcomes. Medical facilities, including hospitals and ambulatory surgery centers, invest heavily in advanced electrophysiology devices.

Reimbursement policies and next-generation devices, like AI-powered m

At a cost of around *** thousand U.S. dollars, heart valve replacements were among the most expensive surgeries in the United States as of 2021. Other surgeries that cost over 100 thousand U.S. dollars at that time included bypass surgery and spinal fusion surgery. However, these prices are not complete because they do not include airfare travel or lodging costs for the patient (and companion). On the other hand, there might be variations due to factors like type of hospital, doctor’s experience, accreditation, currency exchange rates, etc. Higher health care costs in the U.S. Increasing health care costs in the U.S. are driven by many things, but the increased use of technology is a strong driver of rising health care costs. The electrosurgical segment of the surgical instrument market has grown in recent years and is expected to continue to grow. Other forms of medical technology are also on the rise, such as forms of digital health, electronic medical records, and diagnostics. The U.S. digital health market has grown and is expected to see significant gains in the coming years. Heart surgeries Some of the most frequent operations performed in the U.S. include cesarean sections, arthroplasty of the knee and percutaneous coronary angioplasty. The cost of heart bypass surgeries in the U.S. is significantly higher than the cost of bypass surgeries in other countries around the world. It is projected that the cost of treating coronary heart disease will exceed the cost of treating many other cardiovascular diseases. The cost increase is clearly seen in the increase in surgical treatment prices. Since 2005, the cost of a coronary angioplasty surgical treatment in the U.S. has nearly doubled.

North America Patient Care Monitoring Market size was valued at USD 18.63 Billion in 2023 and is projected to reach USD 27.84 Billion by 2031, growing at a CAGR of 5.1% from 2024 to 2031.

Key Market DriversRising Prevalence of Chronic Diseases: The rising prevalence of chronic diseases such as cardiovascular disease, diabetes, and respiratory disorders is propelling the patient care monitoring market in North America. According to the Centers for Condition Control and Prevention (CDC), roughly six out of every ten persons in the United States have a chronic condition, with heart disease, cancer, and diabetes being the top causes of mortality and disability. This enormous patient population increases the demand for patient monitoring systems, which help manage and track patient health, particularly for chronic illness management. Increasing Adoption of Home Healthcare Solutions: North America has seen a trend toward home healthcare, which is driving the patient care monitoring industry. According to the US Census Bureau, by 2030, all Baby Boomers will be 65 or older, increasing the demand for home healthcare services. Furthermore, the CDC predicts that the demand for home health care will increase as the population ages. Remote monitoring systems, wearable health trackers, and telemedicine solutions are becoming increasingly popular as aging people and those with chronic ailments seek more convenient and individualized care.

The global market for used and refurbished medical devices is experiencing robust growth, driven by increasing healthcare costs, a rising demand for affordable healthcare solutions, and a growing preference for sustainable practices within the medical industry. The market size in 2025 is estimated at $12.4 billion, demonstrating significant scale. While the provided CAGR (XX) is missing, a reasonable estimation, considering typical growth in this sector and related market reports, would place the CAGR in the range of 8-10% for the forecast period (2025-2033). This suggests a substantial expansion of the market over the next decade, reaching a projected value significantly exceeding $25 billion by 2033. Key market drivers include the increasing affordability of refurbished equipment compared to new devices, particularly in emerging markets and budget-conscious healthcare facilities. Furthermore, technological advancements in refurbishment processes are improving the quality and reliability of used medical devices, leading to enhanced confidence among buyers. The market is segmented by device type (including medical imaging, surgical devices, patient monitors, and cardiology devices), application (hospitals, clinics, nursing homes), and region, with North America and Europe currently holding significant market share. However, rapid growth is expected in Asia-Pacific regions due to increasing healthcare infrastructure development and rising disposable incomes. Challenges include managing the regulatory landscape surrounding refurbished devices and ensuring the consistent quality and safety standards across the market. The continued expansion of the used and refurbished medical device market is fueled by a convergence of factors. Hospitals and clinics are increasingly adopting cost-effective strategies to manage operational expenses without compromising quality of care. The environmental benefits of extending the lifespan of medical equipment are also gaining traction, aligning with global sustainability initiatives. Moreover, the rise of specialized refurbishment companies specializing in servicing and maintaining used devices indicates a growing market maturity. The consistent influx of newer technologies also contributes to the availability of high-quality used equipment, further fueling the market's growth trajectory. Future growth will likely be impacted by advancements in refurbishment technologies that further enhance the functionality and lifespan of used medical devices, potentially making them even more competitive with new equipment options. This creates considerable opportunity for both providers of refurbished devices and the healthcare systems looking to maintain budgets while still offering top-tier patient care.

From 2019 to 2020, physicians specialized in cardiology (invasive) generated an average net annual revenue of 3,484,375 U.S. dollars for hospitals in the United States. This statistic illustrates the average net annual hospital revenue generated by physicians in the United States from 2019 to 2020, by specialty.